Coya Therapeutics Inc.

COYA | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.23

+$0.28 (+5.66%)

Sep 22, 2026, 2:06 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-21.23M	-14.88M	-7.99M	-12.24M	-4.89M	-733K
Depreciation & Amortization	27.36K	27.36K	27.36K	27.36K	16.13K	n/a
Stock-Based Compensation	4.29M	2.66M	872.25K	207.35K	233.22K	n/a
Other Working Capital	4.41M	-6.1M	2.56M	-93.45K	74K	-27.27K
Other Non-Cash Items	2.29M	25K	543.19K	4.02M	-399.68K	263.78K
Deferred Income Tax	n/a	n/a	n/a	n/a	399.68K	n/a
Change in Working Capital	3.88M	1.88M	-4.64M	751.84K	739.17K	77.95K
Operating Cash Flow	-10.74M	-10.29M	-11.19M	-7.24M	-3.9M	-391.27K
Capital Expenditures	n/a	n/a	n/a	n/a	-136.8K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-25K	-543.19K	-525K	n/a	n/a
Investing Cash Flow	-1.16M	-25K	-543.19K	-525K	-136.8K	n/a
Debt Repayment	n/a	n/a	n/a	10.47M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	2.02M	89.95K	-1.11M	-341.9K	400
Financial Cash Flow	20.39M	16.03M	38.43M	9.36M	-340.58K	9.11M
Net Cash Flow	8.48M	5.71M	26.69M	1.59M	-4.38M	8.72M
Free Cash Flow	-10.74M	-10.29M	-11.19M	-7.24M	-4.04M	-391.27K
Adj. Free Cash Flow	-15.03M	-12.95M	-12.06M	-7.45M	-4.27M	-391.27K
Maintenance CapEx	n/a	n/a	n/a	n/a	-16.13K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-120.67K	n/a
Owner Earnings	-10.74M	-10.29M	-11.19M	-7.24M	-3.92M	-391.27K